Context Therapeutics
CNTX
CNTX
22 hedge funds and large institutions have $3.58M invested in Context Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.05M | |
| 2 | +$428K | |
| 3 | +$105K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$76.3K |
| 5 |
CHAM
Clear Harbor Asset Management
Stamford,
Connecticut
|
+$57.6K |
Top Sellers
| 1 | -$46.2K | |
| 2 | -$23K | |
| 3 | -$13.8K | |
| 4 |
Two Sigma Advisers
New York
|
-$9.11K |
| 5 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
-$4.67K |